Global Hormone Replacement Therapy Market Is Estimated To Be Valued At US$ 13,556.7 Million 2022 And Exhibit A CAGR Of 5.4% During The Forecast Period (2022-2030)

 

 

Hormone Replacement Therapy Market

When the body of the human being is unable to manufacture enough hormones, hormone replacement therapy is used. Menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency diseases are all treated with it. Hot flashes, night sweats, vaginal dryness, soreness, itching, or burning during sex, bone loss, poor sex-drive, mood swings, and irritability are indications that a person needs hormone replacement medication.

When the body doesn't produce enough natural hormones, hormone replacement therapy (HRT) uses hormones to replace them. For instance, thyroid and human development hormone patients may receive hormone replacement treatment. Additionally, HRT was typically recommended to menopausal people to help with their side effects, such as hot flushes, night sweats, restless influences, mental and genito-urinary issues (urinary recurrence and vaginal dryness), as well as for the prevention of osteoporosis. Additionally, a study of 2,000 American women aged 30 to 60 found that about 47% of the population may experience the negative impacts of hormonal imbalance by 2020.

Global Hormone Replacement Therapy Market Is Estimated To Be Valued At US$ 13,556.7 Million In 2022 And Is Expected To Exhibit A CAGR Of 5.4% During The Forecast Period (2022-2030).

The main factors that influence the growth of the global market for hormone replacement treatment include the prevalence of menopausal problems and an increase in women's awareness of post-menopausal problems. The expansion of the hormone replacement therapy industry is also expected to be significantly aided by new hormone replacement therapy launches. However, negative effects of hormone replacement treatment and the high cost of therapy are anticipated to restrain market growth during the projected time period.

The Global Hormone Replacement Therapy Market is expected to be significantly impacted by the COVID-19 pandemic. The use of hormone replacement therapy in COVID-19-infected patients has been the subject of an increasing number of investigational investigations. For instance, the endurance rate in post-menopausal women infected with SARS-CoV-2 who were taking a regular dosage of exogenous estradiol for post-menopausal complaints was considered as high, according to the investigation paper published in BMC Medicine, 2020.

Additionally, Stony Brook University began a stage 2 clinical study in April 2020 to examine the role of oestrogen in reducing the severity of COVID-19 adverse effects in comparison to standard care, with the administration of estradiol through a transdermal patch for a brief period of 7 days.

Major players operating in the global hormone replacement therapy market include Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company.

Read the Press Release of Global Hormone Replacement Therapy Market

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19